Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

CRISPR-CAS9 gene editing complex.

The CRISPR–Cas9 enzyme complex (blue and grey) edits DNA (purple). Participants in one of the earliest clinical trials of a CRISPR-based therapy experienced no serious side effects. Credit: Ella Maru Studio/Science Photo Library

CRISPR-Cas9 genome editing

CRISPR gene editing proves safe in a clinical trial

Immune cells whose genomes have been altered with CRISPR are well-tolerated by three people with cancer.

Preliminary results from one of the earliest clinical trials of CRISPR—Cas9 provide evidence that the technique is safe and feasible to use for treating human diseases.

‘Designer’ immune cells with enhanced abilities to seek and attack tumours have shown promise in treating some cancers. But researchers would like to improve methods to bolster immune cells’ cancer-fighting powers. One option is the use of CRISPR–Cas9, a method for making targeted changes to the genome.

Edward Stadtmauer and Carl June at the University of Pennsylvania in Philadelphia and their colleagues collected immune cells called T cells from three people with cancer. Using a conventional genetic-engineering method, the team gave the T cells the ability to recognize a protein produced by some cancer cells. The researchers also used CRISPR–Cas9 to block the T cells’ production of three proteins that might inhibit the cells’ ability to target tumours.

After being reintroduced into the trial participants’ bodies, the T cells thrived for at least 9 months without causing any significant side effects. However, cancer in all three participants has since continued to progress.

More Research Highlights...

Pulsar wind nebula illustration

Curving purple lines in this artist’s impression represent the magnetic field of a neutron star (white sphere) left over from a brilliant supernova. Credit: Salvatore Orlando/INAF-Osservatorio Astronomico di Palermo

Astronomy and astrophysics

X-rays expose a clue to the mystery of the missing neutron star

Astronomers might have spotted the long-sought debris of a famous stellar explosion.
A bone fragment next to a dime

A bone fragment excavated in Southeast Alaska belonged to one of the earliest known domestic dogs in the Americas. Credit: Douglas Levere/University at Buffalo


An ancient Alaskan dog’s DNA hints at an epic shared journey

To scientists’ surprise, a 10,000-year-old bone found in an Alaskan cave belonged to a domestic dog — one of the earliest known from the Americas.
Emissions billow from smokestacks at a coal-fired power plant as the sun sets, India.

Black carbon emitted by power plants and other sources in Asia wafts to the Arctic, where the pollution accelerates the melting of ice and snow. Credit: Kuni Takahashi/Bloomberg/Getty

Atmospheric science

Soot from Asia travels express on a highway to the high Arctic

Black carbon from fuel combustion in South Asia bolsters the effects of climate change on northern ice and snow.
Prevotella copri bacteria, computer illustration

The gut bacterium Prevotella copri (artist’s impression) has been linked to a reduction in the health benefits of a diet that skimps on red meat in favour of fish and vegetables. Credit: Kateryna Kon/Science Photo Library


Trying a Mediterranean diet? Gut microbes might sway the outcome

The composition of a person’s microbiome could influence the health effects of swapping steak for vegetables and olive oil.
Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links